VRAX
Virax Biolabs Group Limited Ordinary Shares
$3.13
-1.88%
-0.06
Notify me if price changes either direction
Buy VRAX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.5M
Enterprise value
-4098853
Trailing PE
-0.24762658227848
Forward PE
-0.6066667
PEG Ratio
-0.6066667
Enterprise to EBITDA
0.678
Enterprise to revenue
-329.941
Price to book MRQ
0.27824494
Price to sales TTM
233.52138
Financials
Fiscal Year Ends
2026-03-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
12423
EBITDA
-6048149
Diluted EPS TTM
-12.64
Total Cash (MRQ)
6.5M
Current ratio (MRQ)
9.968
Operating Cash Flow (TTM)
-4621892
VRAX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
